Tuberculosis
Eli Lilly and Co. unveils global partnership to battle MDR-TB
Published in TB and Outbreaks Week, July 1st, 2003
Eli Lilly and Co. (LLY) unveiled a global effort with the World Health Organization (WHO), the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention (CDC), Brigham and Women's Hospital (BWH), an affiliate of Harvard Medical School, and Purdue University to increase the number of trained personnel and drugs available to treat the expanding crisis of Multi-Drug Resistant Tuberculosis (MDR-TB).
As part of this pioneering effort, Lilly will:
1) Transfer its technology to manufacture two antibiotics necessary for treatment of MDR-TB to nations where the disease is most prevalent;
2) Establish a Center...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Infectious Disease Vaccine
DNA immunization effective against MRSA - Tuberculosis Pathogenesis
Genetic locus linked to resistance in mice - Critical Care Medicine
Novel liquid occlusive effective for wound dressing - Drug Development
New range of antibiotics may present a threat to public health, biologists say - Malaria
Permethrin-treated bed nets reduce mortality in young children in Kenya - Tuberculosis Therapy
Rifampicin, dexamethasone differ in immunomodulatory effects - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
